drugset / Trial / NCT03437330
Empagliflozin Effect on Glucose Toxicity
RandomizedParallel-groupOpen-labelTreatment
Summary
Empagliflozin effect on glucose toxicity in type 2 diabetes patients - a randomized, open-label, controlled, parallel group, exploratory study
Timeline
- Start
- 2021-10-27
- Primary completion
- 2023-05-03
- Completion
- 2023-05-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Empagliflozin | Small molecule | 10 mg | Oral |
| Comparator | insulin glargine | Protein / enzyme biologic | — | — |